Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome Negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00446173
What this trial is testing

Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06738368
What this trial is testing

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeT Acute Lymphoblastic Leukemia
University of Washington 30
Not applicableStudy completedNCT03417817
What this trial is testing

Oesophageal Acid Exposure in Healthy Subjects Over 96 Hours

Who this might be right for
Gastroesophageal Reflux
Guy's and St Thomas' NHS Foundation Trust 50
Early research (Phase 1)Study completedNCT01456676
What this trial is testing

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Who this might be right for
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 11
Large-scale testing (Phase 3)Study completedNCT01037231
What this trial is testing

Phase 2/3 Oxabact Study

Who this might be right for
Primary Hyperoxaluria
OxThera 36
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT03884465
What this trial is testing

Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Liquidia Technologies, Inc. 15
Early research (Phase 1)Study completedNCT01759875
What this trial is testing

Effects of Gastric pH on the Pharmacokinetics of Atazanavir

Who this might be right for
Healthy
University of California, San Francisco 8
Not applicableLooking for participantsNCT07227831
What this trial is testing

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

Who this might be right for
HER2-negative Breast CancerHormone Receptor Positive TumorAdvanced Breast Cancer+1 more
Barbara Ann Karmanos Cancer Institute 82
Large-scale testing (Phase 3)Study completedNCT01726075
What this trial is testing

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
BCN Peptides 450
Not applicableStudy completedNCT03934515
What this trial is testing

End-Tidal CO2 (etCO2) and pH in the Correct Naso-gastric Tube Placement

Who this might be right for
Gastric Feeding TubeBlood Gas Monitoring, TranscutaneouspH
Clinica Luganese Moncucco 85
Large-scale testing (Phase 3)Study completedNCT00322452
What this trial is testing

First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 1,329
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Not applicableUnknownNCT05330091
What this trial is testing

Garden of Life Once Daily Women's Probiotic: Vaginal pH and Quality of Life Study

Who this might be right for
Vaginal Health
Garden of Life, LLC 200
Very early researchStudy completedNCT04480723
What this trial is testing

The Identification of Biomarker Signatures for Diagnosis of Pulmonary Hypertension (PH) in Participants at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging

Who this might be right for
Hypertension, Pulmonary
Actelion 86
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07245797
What this trial is testing

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC

Who this might be right for
Breast Cancer
Zhimin Shao 164
Not applicableUnknownNCT05886569
What this trial is testing

DIGIPREDICT-Physio-DE

Who this might be right for
Biomarkers
Charite University, Berlin, Germany 20
Next Page